Olszewski, Adam J <br/><br/>
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.  [electronic resource] 

 -  Leukemia research  Aug 2014 
 - 866-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2014.04.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Medicare<br/>Prednisone--therapeutic use<br/>Retrospective Studies<br/>Rituximab<br/>SEER Program<br/>Survival Analysis<br/>United States--epidemiology<br/>Vincristine--therapeutic use